You Are Invited to an Evening Meeting

Current State and Challenges of the Life Science Industry 

Featuring Local Industry Executives

Ed Bjurstrom of Gilead Sciences and Shawn Ansari of Shire



Shawn Ansari of Shire



    Ed Bjurstrom of Gilead Sciences


With Tours of KGI's Amgen Bioprocessing Center (ABC)

Sponsorships Available  


  • Diana Bartlett, Associate Vice President, Corporate Partnerships, KGI
  • Jeremy Garibay, President, KGI Student Chapter, ISPE

Program Managers

  • Paul Crissman, Principal, Biotechnical Solutions
  • Merritt Postma, Director Western Region, SKAN


  • Shawn Ansari, VP of Engineering, Biologics and Small Molecule Operating Units, Shire
  • Ed Bjurstrom, VP Operations Gilead Sciences


4:30-5:30pm   Registration and Networking Happy Hour with Appetizers, Beer and Wine (Building 517)
Attendees will have the chance to review graduate student posters during the networking hour
5:30-6:30pm Tours of Amgen Bioprocessing Center (Building 535 across the street)
6:30-8:00pm   Dinner and Presentations in Building 517 Founders’ Room

About the Speakers

Shawn Ansari is Vice President, Head of Engineering and Validation for Biologics and Small Molecule Operation Units for Shire. He is directly responsible for Engineering and Validation organizations within Shire's Technical Operations at all Biologics Manufacturing Sites located in the US, Singapore, Austria, Switzerland, Ireland, as well as the Small Molecule external Manufacturing Network. He is responsible for over 500 full-time employees and over 100 contractors, the associated OPEX and CAPEX budgets across the internal sites. He provides the global support out of Shire’s office located in Thousand Oaks, CA.

Previously he has held Senior Director of Engineering positions at Baxalta/Baxter and prior to that he was the Head of Facilities and Engineering at Shire Regenerative Medicine in La Jolla, Amgen, and spent sixteen years at Eli Lilly in Indiana.

Shawn has a BS in Chemistry from Thomas More University, a MS in Chemical Engineering at Purdue and an MBA from the Krannert Executive Program at Purdue.

Ed Bjurstrom is the Vice President and General Manager for the Gilead Sciences manufacturing facilities in San Dimas and La Verne, CA. The San Dimas site is responsible for the manufacturing of AmBisome®, which is used to treat life-threatening fungal infections, including a specific form of meningitis in people infected with HIV. The facility also labels, packages and distributes more than 20 of the company’s products throughout the Americas and the Pacific Rim, including Gilead’s cure for hepatitis C.

Ed started his career in the biopharma industry at Amgen where he had numerous roles, and left as the Vice President of Operations. After his 18-year career with Amgen, he held leadership positions at CURE Pharmaceutical, NovaRx and Abgenix. He also founded CompassioNow, a non-profit organization dedicated to establishing and supporting effective medical care in African locations where the most basic healthcare is unavailable. 

He has a BS in Chemical Engineering from Cal State Long Beach.